These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36413741)

  • 21. End-of-life quality metrics among medicare decedents at minority-serving cancer centers: A retrospective study.
    Wasp GT; Alam SS; Brooks GA; Khayal IS; Kapadia NS; Carmichael DQ; Austin AM; Barnato AE
    Cancer Med; 2020 Mar; 9(5):1911-1921. PubMed ID: 31925998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How Do Claims-Based Measures of End-of-Life Care Compare to Family Ratings of Care Quality?
    Christian TJ; Hassol A; Brooks GA; Gu Q; Kim S; Landrum MB; Keating NL
    J Am Geriatr Soc; 2021 Apr; 69(4):900-907. PubMed ID: 33165965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.
    Fletcher SA; Cronin AM; Zeidan AM; Odejide OO; Gore SD; Davidoff AJ; Steensma DP; Abel GA
    Cancer; 2016 Apr; 122(8):1209-15. PubMed ID: 26914833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations Between End-of-Life Expenditures and Hospice Stay Length Vary by Clinical Condition and Expenditure Duration.
    Hung P; Hsu SH; Wang SY
    Value Health; 2020 Jun; 23(6):697-704. PubMed ID: 32540226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of end-of-life care patterns between older patients with both cancer and Alzheimer's disease and related dementias versus those with only cancer.
    Weng X; Shen C; Van Scoy LJ; Boltz M; Joshi M; Wang L
    J Geriatr Oncol; 2022 Nov; 13(8):1111-1121. PubMed ID: 36041992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma.
    Chow RD; Long JB; Hassan S; Wheeler SB; Spees LP; Leapman MS; Hurwitz ME; McManus HD; Gross CP; Dinan MA
    JNCI Cancer Spectr; 2023 May; 7(3):. PubMed ID: 37202354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of Care in Patients with Metastatic Renal Cell Carcinoma Among a U.S. Payer Population with Commercial or Medicare Advantage Membership.
    Miller LA; Stemkowski S; Saverno K; Lane DC; Tao Z; Hackshaw MD; Loy B
    J Manag Care Spec Pharm; 2016 Mar; 22(3):219-26. PubMed ID: 27003551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada.
    Ho TH; Barbera L; Saskin R; Lu H; Neville BA; Earle CC
    J Clin Oncol; 2011 Apr; 29(12):1587-91. PubMed ID: 21402603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic burden of selected adverse events in patients aged ≥65 years with metastatic renal cell carcinoma.
    Hagiwara M; Hackshaw MD; Oster G
    J Med Econ; 2013 Nov; 16(11):1300-6. PubMed ID: 24004437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Family Perspectives on Aggressive Cancer Care Near the End of Life.
    Wright AA; Keating NL; Ayanian JZ; Chrischilles EA; Kahn KL; Ritchie CS; Weeks JC; Earle CC; Landrum MB
    JAMA; 2016 Jan; 315(3):284-92. PubMed ID: 26784776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
    Hung YN; Liu TW; Wen FH; Chou WC; Tang ST
    Oncologist; 2017 Apr; 22(4):460-469. PubMed ID: 28232596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Hospice Length of Stay, Health Care Utilization, and Medicare Costs at the End of Life Among Patients Who Received Maintenance Hemodialysis.
    Wachterman MW; Hailpern SM; Keating NL; Kurella Tamura M; O'Hare AM
    JAMA Intern Med; 2018 Jun; 178(6):792-799. PubMed ID: 29710217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Provision of spiritual support to patients with advanced cancer by religious communities and associations with medical care at the end of life.
    Balboni TA; Balboni M; Enzinger AC; Gallivan K; Paulk ME; Wright A; Steinhauser K; VanderWeele TJ; Prigerson HG
    JAMA Intern Med; 2013 Jun; 173(12):1109-17. PubMed ID: 23649656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma.
    Miller SM; Wilson LE; Greiner MA; Pritchard JE; Zhang T; Kaye DR; Cohen HJ; Becher RD; Maerz LL; Dinan MA
    J Geriatr Oncol; 2022 Jun; 13(5):635-643. PubMed ID: 34996724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health Care Access Dimensions and Racial Disparities in End-of-Life Care Quality among Patients with Ovarian Cancer.
    Karanth S; Osazuwa-Peters OL; Wilson LE; Previs RA; Rahman F; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
    Cancer Res Commun; 2024 Mar; 4(3):811-821. PubMed ID: 38441644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depression and Health Care Utilization at End of Life Among Older Adults With Advanced Non-Small-Cell Lung Cancer.
    McDermott CL; Bansal A; Ramsey SD; Lyman GH; Sullivan SD
    J Pain Symptom Manage; 2018 Nov; 56(5):699-708.e1. PubMed ID: 30121375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Intensity of End-of-Life Care Among Adolescent and Young Adult Cancer Patients in the New York State Medicaid Program.
    Mack JW; Chen K; Boscoe FP; Gesten FC; Roohan PJ; Schymura MJ; Schrag D
    Med Care; 2015 Dec; 53(12):1018-26. PubMed ID: 26492211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Data Sharing Between a Comprehensive Cancer Center and a Private Payer to Better Understand Care at the End of Life.
    Stuver SO; McNiff K; Fraile B; Odejide O; Abel GA; Dodek A; Jacobson JO
    J Pain Symptom Manage; 2016 Aug; 52(2):161-9. PubMed ID: 27033156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial Disparities in Health Care Utilization at the End of Life Among New Jersey Medicaid Beneficiaries With Advanced Cancer.
    Yang A; Goldin D; Nova J; Malhotra J; Cantor JC; Tsui J
    JCO Oncol Pract; 2020 Jun; 16(6):e538-e548. PubMed ID: 32298223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries.
    Doshi JA; Jahnke J; Raman S; Puckett JT; Brown VT; Ward MA; Li P; Manz CR
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1457-1468. PubMed ID: 34595957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.